17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Pseudoangiomatous stromal<br />

hyperplasia<br />

Definition<br />

A benign lesion consisting of complex<br />

anastomosing slit-like pseudovascular<br />

spaces, that are either acellular or lined<br />

by slender spindle-shaped stromal cells.<br />

Fig. 1.133 Pseudoangiomatous stromal hyperplasia (PASH). Interanastomosing, empty, slit-like spaces<br />

within <strong>breast</strong> stroma are typical.<br />

Pathology<br />

M a c roscopic and histopathological<br />

appearances are similar to angiomatosis<br />

at other sites. The haemorrhagic spongy<br />

lesions are composed of usually thin<br />

walled large blood or lymphatic vessels<br />

d i ffusely extending throughout the<br />

parenchyma of the <strong>breast</strong>.<br />

Prognosis and predictive factors<br />

R e c u r rence after incomplete excision<br />

has been reported, and may occur after<br />

a long disease-free interval {2416}. In<br />

many cases, complete excision requires<br />

a mastectomy.<br />

Haemangiopericytoma<br />

Definition<br />

A circumscribed area of bland ovoid to<br />

spindled cells proliferating aro u n d<br />

branching and “stag-horn” vessels.<br />

ICD-O codes<br />

Benign 9150/0<br />

NOS 9150/1<br />

Malignant 9150/3<br />

Epidemiology<br />

This is a rare mesenchymal tumour.<br />

A round 20 primary haemangiopericytomas<br />

have been reported in the <strong>breast</strong>.<br />

The patients are mostly women aged<br />

22–67, but a few cases have been<br />

reported in children (5 and 7 years old)<br />

and in men {118,2889}.<br />

Clinical features<br />

Patients usually present with a mass that<br />

appears as a well circumscribed area of<br />

density on mammography.<br />

Macroscopy<br />

The tumours are round to oval, well circumscribed<br />

and range in size from 1 to<br />

19 cm {118,1415,2855,2889}. They are<br />

firm with a solid, yellow-tan to grey-white<br />

cut surface. Myxoid areas alternate with<br />

small cysts filled with watery fluid.<br />

Haemorrhage and necrosis are evident<br />

in some larger tumours.<br />

Histopathology<br />

The histological and immunophenotype<br />

appearances are similar to haemangiopericytomas<br />

described elsewhere {2889}.<br />

They are composed of a compact pro l i f e-<br />

ration of plump ovoid to spindle cells with<br />

indistinct cell margins arranged aro u n d<br />

an abundance of usually thin-walled,<br />

i r regularly branching vascular channels.<br />

Some of the branching vessels assume<br />

a “stag-horn” configuration. Mammary<br />

ducts and ductules are often trapped<br />

focally in the periphery of the lesion.<br />

Prognosis and predictive factors<br />

Most cases of mammary haemangiopericytoma<br />

have been benign. There is<br />

no well documented example of metastatic<br />

disease or even re c u r rence {118,<br />

1415,2855,2889}. Wide local excision<br />

rather than mastectomy is often sufficient<br />

for complete tumour excision.<br />

Epidemiology<br />

The clinicopathological spectrum of mamm<br />

a ry pseudoangiomatous stromal hyperplasia<br />

(PASH) extends from insignificant<br />

m i c roscopic changes, often associated<br />

with either benign or malignant <strong>breast</strong> disease,<br />

to diffuse involvement of the bre a s t<br />

or cases where a localized palpable or<br />

non-palpable <strong>breast</strong> mass is pro d u c e d<br />

(nodular PASH) {1275,2270,3037}. The<br />

latter is uncommon and re p o rted to occur<br />

in 0.4% of <strong>breast</strong> biopsies {2270}. Focal or<br />

multifocal PASH without mass form a t i o n<br />

has been re p o rted in 23% of <strong>breast</strong> biopsies,<br />

usually as an incidental finding.<br />

PASH has been re p o rted in at least 25%<br />

of cases of gynaecomastia {157,1865}.<br />

Aetiology<br />

The immunophenotype of the proliferating<br />

cells confirms that PASH is of myofibroblastic<br />

origin {1113,2279,2510,3249}.<br />

The pseudoangiomatous spaces are<br />

also discernible in frozen sections, indicating<br />

that they are not a fixation artefact<br />

{157,3037}.<br />

Clinical features<br />

Nodular PASH usually present as a<br />

painless, well circumscribed, mobile<br />

palpable mass, clinically indistinguishable<br />

from fibroadenoma {532,1275,<br />

2270,2279,3037,3249}. Smaller lesions<br />

may be detected by mammography<br />

{532, 2270}. On imaging, nodular PA S H<br />

is indistinguishable from fibro a d e n o m a<br />

{2270}. Diffuse lesions are an incidental<br />

finding {1275}. Bilateral lesions may<br />

occur {157}. Rapid growth has been<br />

re p o rted {532,2270,2765,3026}.<br />

Macroscopy<br />

Macroscopically, nodular PASH is usually<br />

indistinguishable from fibroadenoma<br />

ranging in size from 1 to 17 cm. The cut<br />

surface is pale tan-pink to yellow {92,<br />

1275,2279,2622,3037}.<br />

Histopathology<br />

PASH may be present in normal bre a s t<br />

tissue or in various benign lesions {867,<br />

90 Tumours of the <strong>breast</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!